Delivery Order SPE2D021DA002-SPE2D324F153N

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,630.87 firm fixed-price delivery order is for the procurement of Procainamide HCL, a specialized medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,605.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract, which has no set-aside designation, is for the provision of procainamide hydrochloride injection USP, a medication primarily used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant indefinite delivery...
This federal contract award, with ID SPE2D021DA002|SPE2D325F1756, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,210.30 firm fixed-price delivery order is for the provision of Procainamide Hydrochloride Injection USP, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a type of pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a medication used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,530.61 firm fixed-price delivery order is for the supply of 4567197181 procainamide 1 gram/10 ml vials. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,246.42, covers the procurement of Procainamide Hydrochloride, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...
The U.S. Defense Logistics Agency (DLA) awarded a $1,605.15 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, issued under the DLA's SPE2DB program, is for the delivery of Procainamide Hydrochloride Injection USP, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is not associated with a...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is valued at $5,470.89 and has an ultimate completion date of May 1, 2025. The contract was awarded by the Defense Logistics Agency (DLA) to provide procainamide hydrochloride, a pharmaceutical product, to support the medical supply needs of federal agencies. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,155.02, is for the delivery of Procainamide 1 gram/10 ml vial (10 ml) to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F153N
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois, is a firm fixed-price delivery order (SPE2D021DA002|SPE2D324F153N) valued at $1,605.15. The award is for the supply of Procainamide Hydrochloride Injection USP, a common pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD).

The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Through this vehicle and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications to DoD healthcare facilities, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 10/25/24, 9:41 AM